The preclinical study demonstrated that magnolia combined with BRAF inhibitor SB590885 inhibited the proliferation and migration of HCC cells, by targeting the ERKs/RSK2 signaling pathway (82). This evidence concerns the gene BRAF and hepatocellular carcinoma.